Organization
University of Utah, Salt Lake City, UT
3 abstracts
Abstract
UPGRADE-A: Phase 1 expansion trial of the NaPi2b-directed antibody drug conjugate (ADC) upifitamab rilsodotin (UpRi) in combination with carboplatin in patients with high-grade serous ovarian cancer (HGSOC).Org: Wexner Medical Center and The James Cancer Hospital, Ohio State University, Columbus, OH, Memorial Sloan Kettering Cancer Center, New York, NY, USA, START Midwest, Grand Rapids, MI, Willamette Valley Cancer Institute, Eugene, OR, Arizona Oncology Associates, Tucson, AZ,
Abstract
A RETROSPECTIVE LOOK AT THE RECURRENCE OF DIGITAL ULCERS IN PATIENTS WITH SCLERODERMA AFTER DISCONTINUATION OF ORAL TREPROSTINIL Org: Division of Rheumatology, Johns Hopkins University, Baltimore, University of Michigan, Ann Arbor, MI, Cleveland Clinic, Cleveland, OH, Medical College of Wisconsin, Milwaukee, WI, University of Utah, Salt Lake City, UT,
Abstract
A PHASE 2 STUDY OF SAFETY AND EFFICACY OF ANABASUM (JBT-101) IN SYSTEMIC SCLEROSIS Org: Hospital for Special Surgery, New York City, Johns Hopkins, Baltimore, United States, Stanford, Palo Alto, University of Utah, Salt Lake City, UT, University of Pittsburgh, Pittsburgh, PA,